Alyeska Investment Group
PIII icon

Alyeska Investment Group’s P3 Health Partners PIII Stock Holding History

Alyeska Investment Group’s Portfolio PIII Stock Details PIII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,000
Closed -$45K – 658
2024
Q2 		$45K Buy
+2,000
New +$59.7K ﹤0.01% 548
2024
Q1 		– Sell
-69,084
Closed -$4.87M – 581
2023
Q4 		$4.87M Buy
69,084
+2,000
+3% +$138K 0.03% 310
2023
Q3 		$4.93M Sell
67,084
-2,000
-3% -$208K 0.03% 340
2023
Q2 		$10.3M Buy
+69,084
New +$9.55M 0.08% 264

Other funds holding PIII

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TFA
Trinity Financial Advisors Columbus, Ohio $389M AUM 20.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
NMC
Nine Masts Capital Central, Hong Kong $693M AUM 31.93% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return

Alyeska Investment Group's PIII Position: Q1 2026 in Review

Alyeska Investment Group sold out of P3 Health Partners (PIII) in Q1 2026, closing a stake of 137,406 shares — an estimated $480K sold.

Alyeska Investment Group first reported a position in PIII in Q2 2021 and held it in 13 quarters. The position peaked at $11.5M in Q3 2021. 17 funds tracked by Wall St. Rank hold PIII as of Q1 2026.

  • Alyeska Investment Group reported no remaining P3 Health Partners position as of Q1 2026 after selling out during the quarter.
  • Alyeska Investment Group sold 137,406 P3 Health Partners shares in Q1 2026, an estimated $480K.
  • Alyeska Investment Group first reported a position in P3 Health Partners in Q2 2021 and held it in 13 quarters.
  • Alyeska Investment Group's P3 Health Partners position peaked at $11.5M in Q3 2021.
  • 17 funds tracked by Wall St. Rank held P3 Health Partners as of Q1 2026.

Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.